Technicals

Regal Entertainment (RGC) Catches Eye: Stock Jumps 7.6%

Regal Entertainment Group RGC was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $15.00 to $18.25 in the past one-month time frame […]

Technicals

3 Reasons Why GOL Linhas (GOL) is a Great Momentum Stock

Many investors like to look for momentum in stocks, but this can be very tough to define. There is great debate regarding which metrics are the best to focus on in this regard, and which are not really quality indicators of future performance. Fortunately, with our new style score system we have identified the key statistics to pay close attention to and thus which stocks might be the best for momentum investors in the near term […]

Stock Analysts

Why is Alaska Air Group Stock Down More Than 20% This Year?

Alaska Air Group ALK has confronted multiple headwinds due to the recent hurricanes and escalating costs like many of its fellow airline operators so far in 2017. Consequently, shares of the company have declined 24.2%, significantly underperforming the Zacks Airline industry ’s rally of 15.1% on a year-to-date basis. Lets have a deeper look into the headwinds. […]

Stock Analysts

Is Rice Midstream (RMP) a Great Stock for Value Investors?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. […]

Stock Analysts

AstraZeneca’s Tagrisso Label Expansion Filing Accepted by EMA

AstraZeneca Plc. AZN announced that the European Medicines Agency (EMA) has accepted a variation to the Marketing Authorisation Application (MAAv) for the label expansion of Tagrisso (osimertinib). AstraZeneca is looking to get Tagrisso approved for the first-line treatment of adult patients with locally-advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have EGFR mutations […]

Stock Analysts

Will Vault Platform Aid Veeva Systems (VEEV) in Q3 Earnings?

Veeva Systems Inc. VEEV is scheduled to report third-quarter 2017 results on Dec 5, after market close. The results are expected to show steady growth on Subscription services revenues.Strong growth in the segments is likely to be driven by Veeva Vault, OpenData and the company’s latest technologies in the commercial cloud platform […]

Stock Analysts

Glaxo Submits NDA for Anti Relapse Malaria Medicine to FDA

GlaxoSmithKline plc GSK in partnership with Medicines for Malaria Venture (MMV) filed a new drug application (NDA) with the FDA looking for approval of a single-dose tafenoquine to treat relapsing malaria. Glaxo’s single-dose tafenoquine has been developed as an anti-relapse medicine for patients infected with Plasmodium vivax (P.vivax). […]

Stock Analysts

6 Reasons to Add Terex (TEX) Stock to Your Portfolio Now

Terex Corporation TEX looks promising at the moment on positive market dynamics and product and backlog strength. We are positive on the company’s prospects and believe this is the right time to add the stock to your portfolio, as it is poised to carry the bullish momentum ahead. Let’s delve deeper into the factors that make Terex an attractive investment option […]